Warburg Pincus and The Vertical Group have exited ev3 (NASDAQ: EVVV) through the completion of the company's $2.6 billion sale to Covidien (NYSE: COV). ev3 provides medical devices with a focus on catheter-based technologies for the endovascular treatment of vascular diseases and disorders.
© 2022 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.